Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usage of TruGraf Liver Gene Expression to Identify Subclinical Rejection as Well as Adjust Immunosuppression Medications in Liver Transplant Recipients Due to Autoimmune Disease

NCT06061341 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT06061341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06061341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usage of TruGraf Liver Gene Expression to Identify Subclinical Rejection as Well as Adjust Immunosuppression Medications in Liver Transplant Recipients Due to Autoimmune Disease
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Terminated
Start date
August 1, 2024
Completion date
December 3, 2025
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune hepatitis, autoimmune liver disease, primary biliary cirrhosis, primary sclerosing cholangitis